TerrAscend TSNDF
OTC TSNDF
$0.61 +0.05 (+8.56%)
At close: Aug 19, 2026 · 3:19 PM UTC

TerrAscend (TSNDF) Income from Non-Controlling Interests (2021 - 2026)

TerrAscend (TSNDF) posted quarterly Income from Non-Controlling Interests of $1.1 million for Q1 2026, down 18.89% year-over-year from $1.3 million in Q1 2025, and down 5.04% quarter-over-quarter from $1.1 million in Q4 2025.

TerrAscend (TSNDF) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has reported Income from Non-Controlling Interests for 6 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income from Non-Controlling Interests fell 18.89% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.7 million (down 30.17% YoY), while the FY2025 annual figure was $4.9 million, down 35.24% from the prior year.
  • Income from Non-Controlling Interests declined to $1.1 million in Q1 2026 per TSNDF's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $2.3 million in Q4 2023 and bottomed at $351000.0 in Q1 2022.
  • Historically, Income from Non-Controlling Interests has averaged $1.6 million across 5 years, with a median of $1.7 million in 2024.
  • Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests surged 522.79% — and 2025, when it slumped 40.93%.
  • TerrAscend's Income from Non-Controlling Interests stood at $1.0 million in 2022, then surged by 124.66% to $2.3 million in 2023, then declined by 27.42% to $1.7 million in 2024, then slumped by 34.05% to $1.1 million in 2025, then dropped by 5.04% to $1.1 million in 2026.
  • Business Quant data shows TSNDF's Income from Non-Controlling Interests at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 376,434.15
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 TerrAscend 187.17 Mn 145.05 Mn 36.25 Mn 1.11 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Mn
Mar 31, 2026 1.06 Mn
Dec 31, 2025 1.11 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.30 Mn
Dec 31, 2024 1.69 Mn
Sep 30, 2024 1.73 Mn
Jun 30, 2024 1.94 Mn
Mar 31, 2024 2.20 Mn
Dec 31, 2023 2.32 Mn
Sep 30, 2023 2.16 Mn
Jun 30, 2023 2.14 Mn
Mar 31, 2023 2.19 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 2.23 Mn
Jun 30, 2022 945,000.00
Mar 31, 2022 351,000.00
Dec 31, 2021 556,000.00
Sep 30, 2021 1.41 Mn